The last two years for the medical device market could be summed up as difficult for the industry – as it adjusted to economic turmoil that started in years prior. During a webinar hosted by Millennium Research Group (MRG; Toronto), Adrienne Lovink, vice president of consulting and business development at MRG, gave listener

Dr. Jay Lombard, a neurologist, is the co-founder and chief scientific officer of Genomind (Chalfont, Pennsylvania), a company focused on improving the lives of patients with psychiatric and neurological conditions through biomarker discovery. Lombard has researched and developed several novel therapeutic interventions to treat depression, dementia, and autism.